AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.

AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.

Meiya Yizhen (Beijing) Biotechnology Group Co., Ltd., established on 2015-11-03, The scope of business includes the sale of food;stem cell,Immune cells and biomedical technology development,Technical Services,technical consulting,technology transfer;sell cosmetics.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Develops and manufactures drugs related to immunology, neurobiology and oncology

Jilin Zhongtai Biotechnology Co., Ltd., established on 2009-11-04, Business scope includes Chinese patent medicine,Research on Chemical Drugs and Preparations,to develop,Medical Information Consulting Service,stem cell collection,Production of stem cell preparations,Clinical application of stem cell transplantation technology(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Trustees of Dartmouth College, part of Dartmouth College, is a company headquartered in Hanover, NH. The firm operates higher education institutes. It was founded in 1769.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

Riboao (Guangzhou) Biotechnology Co., Ltd., established on 2009-11-26, Business scope includes medical research and experimental development;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Engineering and Technology Research and Experimental Development;Manufacturing of experimental analysis instruments;Manufacturing of special chemicals(Monitor Chemicals,Excluding hazardous chemicals);Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated);Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals);Import and export(Excluding franchised products);commission agent;Realtor;Space lease(Without storage);Instrument wholesale;Biotechnology Extension Services;Licensed medical device business;Production of medical electronic equipment(The specific production range is<Medical Device Manufacturing Enterprise License>prevail);

Abgenix is a biopharmaceutical company engaged in the discovery, development, and manufacture of human therapeutic antibodies for the treatment of various disease conditions such as cancer, inflammation, and metabolic disease. Its antibody therapeutic product candidates, which are in clinical trials include Panitumumab (ABX-EGF), a human antibody therapeutic product candidate directed against the epidermal growth factor receptor and a candidate for the treatment of various solid tumors.  It also includes ABX-10241 (ABX-PTH), which isa  fully human antibody therapeutic product candidate directed against parathyroid hormone for the treatment of a secondary hyper-para-thyroidism. Abgenix was established in 1996 and is headquartered in Fremont, California. It currently operates as a subsidiary of Amgen, Inc.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

IPMBiotech focuses on the development and application of precision medical technology and cell therapy technology.

Shanghai East Hospital is a Chinese private company located in Shanghai. The firm operates hospital.

Shanghai Mingda Biotechnology Co., Ltd., established on 2014-10-15, The scope of business includes engaging in biotechnology,Technology development in the field of new material science and technology,technology transfer,technical consulting,Technical Services,Software Design and Development,Engaged in the import and export of goods and technology;selling computers,Software and Auxiliary Equipment,cosmetic,Hygienic cleaning products,Wholesale of chemical products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Wuhan Wellcome Gene Technology Co., Ltd., established on 2017-12-05, Business scope includes licensed projects:Inspection and testing service;Experimental animal management;pharmaceutical production;Drug retail;feed production;Feed additive production;Veterinary drug production;Veterinary drug business;Animal Clinic;Import and export;Technology Import and Export;Import and export agency;Drug import and export;Food import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of experimental analysis instruments;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Bio-feed R&D;Feed Additive Sales;pet service(No Animal Treatment);Manufacturing of daily chemical products;Sales of daily chemical products;software development;Artificial intelligence basic software development;Artificial intelligence theory and algorithm software development;Artificial intelligence application software development;Artificial intelligence public service platform technical consulting services;Network and Information Security Software Development;Information Technology Consulting Services;internet data service;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Sales of office equipment consumables;Conference and Exhibition Services;Educational Consulting Services(Education and training activities that do not include licensing approval)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

University of Portsmouth Higher Education Corp. is a British private company. The firm operates as educational institute.